References of "DELANAYE, Pierre"
     in
Bookmark and Share    
Peer Reviewed
See detailVariation of PTH and bone biomarkers in hemodialysis patients.
DELANAYE, Pierre ULg; Warling, X; Moonen, M et al

Poster (2015)

Detailed reference viewed: 6 (4 ULg)
Peer Reviewed
See detailVitamine D et maladie rénale chronique
DELANAYE, Pierre ULg; CAVALIER, Etienne ULg

in Benhamou, CL; Souberbielle, JC (Eds.) La vitamine D chez l’adulte (2015)

Detailed reference viewed: 3 (1 ULg)
See detailGuidelines about CKD classification: a provocative point of view
DELANAYE, Pierre ULg

Conference (2015)

Detailed reference viewed: 4 (0 ULg)
See detailEvaluation de la fonction rénale
DELANAYE, Pierre ULg

Conference given outside the academic context (2015)

Detailed reference viewed: 4 (0 ULg)
See detailPlace de la vitamine D native dans le traitement des patients dialysés
DELANAYE, Pierre ULg

Conference given outside the academic context (2015)

Detailed reference viewed: 8 (2 ULg)
See detailPourquoi et comment corriger les anomalies de la PTH ?
DELANAYE, Pierre ULg

Conference given outside the academic context (2015)

Detailed reference viewed: 3 (0 ULg)
Full Text
See detailRituximab (MabThera®) : nouveau médicament dans les vascularites associées à ANCA
VON FRENCKELL, Christian ULg; DELANAYE, Pierre ULg

in Revue Médicale de Liège (2015), 70(2), 92-100

Detailed reference viewed: 13 (1 ULg)
Full Text
Peer Reviewed
See detailExploration de la fonction glomérulaire rénale : estimation du débit de filtration glomérulaire
Maillard, N; DELANAYE, Pierre ULg; Mariat, C

in Néphrologie & Thérapeutique (2015), 11(1), 54-67

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailAn Age-Calibrated Classification of Chronic Kidney Disease.
Glassock, RJ; DELANAYE, Pierre ULg; El-Nahas, M

in JAMA : Journal of the American Medical Association (2015), 314(6), 559-560

Detailed reference viewed: 13 (2 ULg)
Full Text
Peer Reviewed
See detailSafety of living kidney donation: another brick in the wall…and a solid (physiologic) one.
DELANAYE, Pierre ULg; Mariat, C; Glassock, RJ

in American Journal of Kidney Diseases (2015), 66(1), 1-3

Detailed reference viewed: 5 (1 ULg)
Full Text
Peer Reviewed
See detailThe myth of the future burden of CKD in United States.
DELANAYE, Pierre ULg; El-Nahas, M; Glassock, RJ

in American Journal of Kidney Diseases (2015), 66(1), 171-172

Detailed reference viewed: 6 (1 ULg)
Full Text
Peer Reviewed
See detailLifetime Risk of CKD: What Does It Really Mean?
DELANAYE, Pierre ULg; Glassock, RJ

in Clinical Journal of the American Society of Nephrology (2015), 10(9), 1504-1506

Detailed reference viewed: 3 (0 ULg)
Full Text
Peer Reviewed
See detailGlomerular Filtration Rate and Aging: Another Longitudinal Study--A Long Time Coming!
DELANAYE, Pierre ULg; Glassock, rj

in Nephron (2015), 131(1), 1-4

Detailed reference viewed: 6 (1 ULg)
Full Text
Peer Reviewed
See detailAbnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m2
Pottel, Hans; Hoste, Liesbeth; DELANAYE, Pierre ULg

in Pediatric Nephrology : Journal of the International Pediatric Nephrology Association (2015), 30(5), 821-828

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailKDIGO Guidelines and Kidney Transplantation: Is the cystatin-C Based Recommendation relevant?
Masson, I; Maillard, N; CAVALIER, Etienne ULg et al

in American Journal of Transplantation (2015), 15(8), 2211-4

The KDIGO guidelines propose a new approach to diagnose chronic kidney disease (CKD) based on estimated glomerular ®ltration rate (GFR). In patients with a GFR value comprised between 45 and 59 mL/ min/1 ... [more ▼]

The KDIGO guidelines propose a new approach to diagnose chronic kidney disease (CKD) based on estimated glomerular ®ltration rate (GFR). In patients with a GFR value comprised between 45 and 59 mL/ min/1.73m2 as estimated by the CKD-EPI creatinine equation (eGFRcreat), it is suggested to con®rm the diagnosis with a second estimation using the CKD-EPI cystatin C-based equations (eGFRcys/eGFRcreat-cys). We sought to determine whether this new diagnostic strategy might extend to kidney transplant recipients (KTR) and help to identify those with decreased GFR. In 670 KTR for whom a measured GFR was available, we simulated the detection of CKD using the two-steps approach recommended by the guidelines in comparison to the conventional approach relying on creatinine equation. One hundred forty-®ve patients with no albuminuria had eGFRcreat between 45 and 59 mL/ min/1.73m2. Among them, 23% had inulin clearance over 60 mL/min/1.73m2 and were thus incorrectly classi®ed as CKD patients. When applying the Kidney Disease: Improving Global Outcomes (KDIGO) strategy, 138 patients were con®rmed as having a GFR below 60 mL/min with eGFRcreat-cys. However, 21% of them were misclassi®ed in reference to measured GFR. Our data do no not support the use of cystatin C as a con®rmatory test of stage 3A CKD in KTR. [less ▲]

Detailed reference viewed: 23 (4 ULg)
Full Text
Peer Reviewed
See detailSystematic Analysis of two cystatin C assays using samples of 2057 older adults - The Berlin initiative study
Ebert, natalie; DELANAYE, Pierre ULg; Martus, Peter et al

Poster (2014, November)

Detailed reference viewed: 21 (3 ULg)
Full Text
Peer Reviewed
See detailImpact of the dialysis membrane on the Vitamin D metabolims markers
CAVALIER, Etienne ULg; DUBOIS, Bernard ULg; Urena, Pablo et al

Poster (2014, November)

Detailed reference viewed: 16 (3 ULg)